share_log

Pluri Shares Are Trading Higher After the Company Announced FDA Approval for Mesoblast.

Pluri Shares Are Trading Higher After the Company Announced FDA Approval for Mesoblast.

Pluri股份在公司宣佈獲得FDA對Mesoblast的批准後交易上漲。
Benzinga ·  12/19 22:13

Pluri Shares Are Trading Higher After the Company Announced FDA Approval for Mesoblast.

Pluri股份在公司宣佈獲得FDA對Mesoblast的批准後交易上漲。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論